umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults
Show others and affiliations
2018 (English)In: European Clinical Respiratory Journal, ISSN 2001-8525, Vol. 5, article id 1440868Article, review/survey (Refereed) Published
Abstract [en]

Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma ('difficult asthma') should undergo systematic assessment, in order to differentiate between true severe asthma, and 'difficult-to-treat' patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care.

Place, publisher, year, edition, pages
Taylor & Francis, 2018. Vol. 5, article id 1440868
Keywords [en]
Asthma, severe, prevalence, diagnosis, co-morbidities, management, guideline
National Category
Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:umu:diva-146214DOI: 10.1080/20018525.2018.1440868ISI: 000427092300001PubMedID: 29535852OAI: oai:DiVA.org:umu-146214DiVA, id: diva2:1204601
Available from: 2018-05-08 Created: 2018-05-08 Last updated: 2018-06-09Bibliographically approved

Open Access in DiVA

fulltext(2343 kB)9 downloads
File information
File name FULLTEXT01.pdfFile size 2343 kBChecksum SHA-512
055aa9f27df48c4b0fcf6dffb53ef1e0423df353c0398ae0aaffb1ce0a788ba39981fd48db3e98b5e8ed94e226c1efc125a7d5e9a17f09afca3d1986dec3ac01
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Sandström, Thomas

Search in DiVA

By author/editor
Sandström, Thomas
By organisation
Medicine
In the same journal
European Clinical Respiratory Journal
Respiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar
Total: 9 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 16 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf